HQY Insider Trading Activity and SEC Form 4 Filings
HQY insider trading summary
Over the past 12 months, insiders at Healthequity, Inc. (HQY) reported 11 sales worth $3.3M by 6 insiders and 2 open-market purchases worth $12K by 1 insider on SEC Form 4. Net insider selling was $3.3M.
Latest HQY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Sunil Rajasekar | EVP Chief Prod & Strat Officer | Buy | $10K (108 @ $90.33) |
| Aug 25, 2026 | Adrian T Dillon | Insider | Sell | $140K (1,332 @ $105.26) |
| Aug 25, 2026 | Adrian T Dillon | Insider | Sell | $658K (6,300 @ $104.47) |
| Aug 24, 2026 | Sunil Rajasekar | EVP Chief Prod & Strat Officer | Sell | $11K (108 @ $105.60) |
| Jul 10, 2026 | Michael Henry Fiore | EVP, Chief Commercial Officer | Sell | $224K (2,354 @ $95.00) |
| Jul 8, 2026 | Sunil Rajasekar | EVP Chief Prod & Strat Officer | Buy | $2K (23 @ $95.06) |
| Jul 2, 2026 | Michael Henry Fiore | EVP, Chief Commercial Officer | Sell | $235K (2,470 @ $95.00) |
| May 29, 2026 | Michael Henry Fiore | EVP, Chief Commercial Officer | Sell | $298K (3,142 @ $95.00) |
| Apr 22, 2026 | Sunil Rajasekar | EVP Chief Prod & Strat Officer | Sell | $2K (23 @ $82.81) |
| Dec 19, 2025 | Delano Ladd | EVP, General Counsel | Sell | $142K (1,500 @ $94.72) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.